WSA delivered 1% organic growth and continued improved profitability in the second quarter of FY 2025/26
12.5.2026 07:30:00 CEST | WSA A/S | Press release
Lynge, Denmark – May 12, 2026 – WSA, a leading pure-play hearing healthcare group, today announced results for the second quarter of the financial year 2025/26 (January 1, 2026 – March 31, 2026) showing 1% organic revenue growth and an EBITDA margin improvement of 1.1%-point in line with expectations. The outlook for FY 2025/26 is maintained.

Jan Mäkelä, CEO of WSA, said:
Our organic revenue growth in the second quarter was in line with expectations, and we are continuously improving our profitability. It is encouraging that we are continuing to experience solid momentum in our Online and Retail channels, as well as strong performance in Managed Care. Today, we are launching the Signia Active Mini IX, the world's smallest ready-to-wear hearing aid with the full power of the IX platform. We look forward to launching more breakthrough innovations on our Widex and Signia platforms soon.Highlights Q2 FY 2025/26 (Q2 last financial year in brackets)
- WSA Group delivered organic revenue growth of +1% (+1%) to EUR 628 million. Group reported revenue declined -6% mainly due to currency headwinds.
- The wholesale business delivered organic growth of -6%, impacted by the timing of WSA’s product launches.
- The consumer-facing business delivered +9% organic growth driven by strong performance in Online and Managed Care and solid performance in Retail.
- Revenue growth was mixed across geographies with +4% organic growth in Americas, -3% organic growth in EMEA, and 0% organic growth in APAC.
- EBITDA before special items was EUR 117 million (EUR 117 million). EBITDA margin before special items increased to +18.6%, an improvement of +1.1%-points compared with last year. The improvement was driven by continued operational efficiency improvements and cost reductions made in FY 2024/25.
- Today, WSA launched Signia Mini IX the world’s smallest ready to wear ITE hearing aid with connectivity and the full power of the IX platform in a discreet, rechargeable design. WSA will launch additional significant innovations on the Widex and Signia platforms soon.
- WSA has announced Sound Preference – a significant advance in understanding personalized hearing care. Research conducted by WSA shows that up to 40% of listeners demonstrate a strong and consistent preference for one sound processing philosophy over another. Learn more at soundpreference.com

Highlights 1H 2025/2026 (1H last financial year in brackets)
- In the first six months of FY 2025/26 WSA delivered organic revenue growth of 0% (+3%) to EUR 1,257 million. Group reported revenue declined -6% due to currency headwinds.
- EBITDA before special items declined by EUR -3 million to EUR 228 million with a margin improvement of 0.8%-points. The improvement was driven by continued operational efficiency improvements and cost reductions made in FY 2024/25.
- Outlook for FY 2025/26 is maintained. WSA expects 0 to 4% organic revenue growth supported by our competitive product portfolio and upcoming launches. The range reflects the uncertain macroeconomic environment.
- The EBITDA margin before special items is expected to increase by around 1%-point versus financial year 2024/25, supported by cost reductions made in FY 2024/25, efficiency gains, and growth.
For the full Q2 FY 2025/26 Financial Report, please go to WSA.com/investors/reports
Contacts
Henning Klemmesen
Tel:+45 20 66 66 89Investor.relations@wsa.comUlla LundhusWSA Corporate Communications
Tel:+45 5319 4767ulla.lundhus@wsa.comImages

Documents
Alternative languages
Subscribe to releases from WSA A/S
Subscribe to all the latest releases from WSA A/S by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from WSA A/S
Widex Allure AI RIC with Clarity Boost Now Available in the U.S. and Major European Countries, Redefining How AI Supports Natural Hearing14.10.2026 10:19:49 CEST | Press release
Expansion into 15 additional countries brings Widex natural sound and on-demand AI support to more wearers worldwide 5x more wearers preferred Allure AI RIC with Clarity Boost over key competitors with AI-based denoising in real world listening situations1; Clarity Boost delivers up to 20% better speech understanding in conversations.2 Latest Widex Compass Cloud release reintroduces Zen Therapy, making personalized tinnitus support easier to deliver and incorporate into everyday life LYNGE, DENMARK, October 14, 2026 – Widex, the leading brand in natural sound and part of WSA, today announced the availability of Widex Allure AI RIC with Clarity Boost in 15 additional countries, including the U.S. and major European markets. Building on strong demand and positive feedback from hearing care professionals, the expansion brings Widex’s unique approach to artificial intelligence to more wearers worldwide – preserving Widex’s signature natural sound for everyday listening while giving wearers
New WSA Clinical Studies Link Sound Preference to Higher Hearing Aid Conversion12.10.2026 14:33:03 CEST | Press release
Studies across 42 clinics in three countries found conversion was 5 percentage points higher when individual sound preferences were explored, reinforcing the value of helping patients compare distinct sound designs and identify what sounds right to them LYNGE, Denmark – October 12, 2026 – WSA, a leading hearing healthcare group, today announced new clinical study results showing that hearing aid conversion rates were 5 percentage points higher when individual sound preferences were systematically explored during consultations. Conducted across 42 clinics in Spain, Canada, and the US, the studies found that the approach was associated with a greater likelihood of clients purchasing hearing aids. The findings build on the April launch of WSA Sound Preference, a global program that introduced research and clinical tools to help hearing care professionals understand how individual sound preferences influence hearing aid experiences. The new studies demonstrate the practical value of bringi
Nye kliniske studier fra WSA forbinder lydpræferencer med højere konvertering til høreapparater12.10.2026 14:33:03 CEST | Pressemeddelelse
Undersøgelser foretaget på 42 klinikker i tre lande viste, at konverteringsraten var 5 procentpoint højere, når der blev taget højde for individuelle lydpræferencer, hvilket understreger værdien af at hjælpe patienterne med at sammenligne forskellige lyddesign og finde frem til, hvad der lyder rigtigt for dem LYNGE, Danmark – 12. oktober 2026 – WSA, en førende koncern inden for hørepleje, offentliggjorde i dag resultaterne af nye kliniske undersøgelser, der viser, at konverteringsraten for høreapparater var 5 procentpoint højere, når individuelle lydpræferencer blev systematisk undersøgt under konsultationerne. Undersøgelserne, der blev gennemført på 42 klinikker på tværs af Spanien, Canada og USA, viste, at denne tilgang var forbundet med en større sandsynlighed for, at kunderne købte høreapparater. Resultaterne bygger videre på lanceringen i april af WSA Sound Preference, et globalt program, der introducerede forsknings- og kliniske værktøjer til at hjælpe hørespecialister med at for
WSA udnævner Peter Bøggild til ny CFO16.9.2026 12:02:00 CEST | Pressemeddelelse
Lynge, Danmark – 16. september 2026 – WSA, en førende høreapperatkoncern, meddeler i dag, at Peter Bøggild er blevet udnævnt til ny CFO og medlem af direktionen og ledelsen. Peter Bøggild efterfølger Marianne Wiinholt, der trådte tilbage i slutningen af august for at påtage sig en række bestyrelses- og rådgivningsopgaver. Peter Bøggild tiltræder hos WSA senest den 1. december 2026. Peter kommer til WSA fra Novo, hvor han i mere end 21 år har haft flere ledende stillinger inden for Finance, senest som Senior Vice President for Business Finance og Group Vice President for R&D Performance, Finance & Governance. Jan Mäkelä, CEO for WSA, siger: ”Jeg er glad for at byde Peter Bøggild velkommen til WSA, hvor han vil spille en central rolle i gennemførelsen af vores strategi om at bringe innovation og personlig hørepleje ud til flere mennesker verden over. Han bringer værdifuld og bred erfaring inden for økonomi, strategi og ledelse fra life science-industrien med sig til WSA. Jeg ser frem til
WSA delivered 3% organic growth and improved profitability in the third quarter of FY 2025/2625.8.2026 07:30:00 CEST | Press release
Lynge, Denmark – August 25, 2026 – WSA, a leading pure-play hearing healthcare group, today announced results for the third quarter of the financial year 2025/26 (April 1, 2026 – June 30, 2026) showing 3% organic revenue growth and an EBITDA margin improvement of 2%-points to 19.1%. The outlook for FY 2025/26 is confirmed and narrowed.
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom